Perspective Therapeutics, Inc. (CATX) Institutional Ownership

Ownership Summary

Perspective Therapeutics, Inc. (NYSE:CATX) has 2 institutional investors that have filed 13F reports for the period ending December 2025.

• Collectively, these holders controlled 0.3% of Perspective Therapeutics's outstanding shares in December 2025, down from 1.6% in September 2025.
• They decreased total shares held in Perspective Therapeutics by -79.5% from last quarter, and the number of investors in CATX increased 100.0% annually.
• During the quarter, 0 of these 2 funds increased positions in CATX, 1 reduced exposure, and 1 held steady.
• In total, institutional investors held 250.5K shares in Perspective Therapeutics as of December 2025, down by 971.47K shares quarter on quarter, and up 100.5K shares year over year.
• TCG Crossover Management, LLC is the top holder of Perspective Therapeutics as of December 31, 2025, with 7.92Mn shares representing 10.65% of outstanding stock.
• The most significant purchases of CATX for the quarter ending December 2025 came from TCG Crossover Management, LLC (7.92Mn), Commodore Capital LP (6.34Mn), VANGUARD CAPITAL MANAGEMENT LLC (4.38Mn), CITADEL ADVISORS LLC (3.3Mn), BALYASNY ASSET MANAGEMENT L.P. (2.99Mn).
• Top sellers of CATX stock for the quarter ending December 2025 included Morgan Stanley (1.49Mn), UBS Group AG (405.43K), Nuveen, LLC (363.79K), TWO SIGMA INVESTMENTS, LP (195.17K), Bank Of America Corp /De/ (182.6K).
• Business Quant data shows the 10 biggest positions in Perspective Therapeutics as of December 2025 are held by TCG Crossover Management, LLC (7.92Mn), Commodore Capital LP (6.34Mn), Avidity Partners Management LP (6.05Mn), BlackRock, Inc. (5.35Mn), Opaleye Management Inc. (4.68Mn), VANGUARD CAPITAL MANAGEMENT LLC (4.38Mn), MILLENNIUM MANAGEMENT LLC (4.05Mn), CITADEL ADVISORS LLC (3.57Mn), Affinity Asset Advisors, LLC (3.16Mn), State Street Corp (3.13Mn).